awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26772723-37255307-D4F7-46A5-B4A4-66AAFBEE3998
Q26772723-37255307-D4F7-46A5-B4A4-66AAFBEE3998
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772723-37255307-D4F7-46A5-B4A4-66AAFBEE3998
Inducing and Administering Tregs to Treat Human Disease
P2860
Q26772723-37255307-D4F7-46A5-B4A4-66AAFBEE3998
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772723-37255307-D4F7-46A5-B4A4-66AAFBEE3998
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fee0b075046ada9faf5b0ae9fa856bb631634288
P2860
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.